The impact of race and comorbidity on survival in endometrial cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 5, 2012, Pages 753-760

  Olson, Sara H ^a   Atoria, Coral L ^a   Cote, Michele L ^b   Cook, Linda S ^c   Rastogi, Radhai ^a   Soslow, Robert A ^a   Brown, Carol L ^a   Elkin, Elena B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; ENDOMETRIUM CANCER; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; ENDOMETRIAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 84862883900     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0735     Document Type: Article

References (31)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Fast Stats: An interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute: http://seer.cancer. gov/faststats/ (accessed on 3-19-2012).
3. Sherman ME, Devesa SS. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer 2003;98:176-86. (Pubitemid 36741140)
4. Hill HA, Eley JW, Harlan LC, Greenberg RS, Barrett RJ II, Chen VW. Racial differences in endometrial cancer survival: the black/white cancer survival study. Obstet Gynecol 1996;88: 919-26. (Pubitemid 26391490)
5. Hill HA, Coates RJ, Austin H, Correa P, Robboy SJ, Chen V, et al. Racial differences in tumor grade among women with endometrial cancer. Gynecol Oncol 1995;56:154-63.
6. Farley J, Risinger JI, Rose GS, Maxwell GL. Racial disparities in blacks with gynecologic cancers. Cancer 2007;110:234-43. (Pubitemid 47121882)
7. Allard JE, Maxwell GL. Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer. Cancer Control 2009;16:53-6.
8. Maxwell GL, Tian C, Risinger J, Brown CL, Rose GS, Thigpen JT, et al. Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study. Cancer 2006;107:2197-205. (Pubitemid 44665654)
9. Santin AD, Bellone S, Siegel ER, Palmieri M, Thomas M, Cannon MJ, et al. Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer. Am Journal Obstet Gynecol 2005;192: 813-8. (Pubitemid 40311274)
10. Powell MA, Mutch DG, Rader JS, Herzog TJ, Huang TH, Goodfellow PJ. Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker. Cancer 2002;94: 2941-52. (Pubitemid 34547694)
11. Maxwell GL, Risinger JI, Hayes KA, Alvarez AA, Dodge RK, Barrett JC, et al. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers. Clin Cancer Res 2000;6:2999-3005. (Pubitemid 30637721)
12. Kohler MF, Carney P, Dodge R, Soper JT, Clarke-Pearson DL, Marks JR, et al. p53 overexpression in advanced-stage endometrial adeno-carcinoma. Am J Obstet Gynecol 1996;175:1246-52. (Pubitemid 26398986)
13. Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S. Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc 2007;55:1056-65. (Pubitemid 47024610)
14. Steiner E, Plata K, Interthal C, Schmidt M, Faldum A, Hengstler JG, et al. Diabetes mellitus is a multivariate independent prognostic factor in endometrial carcinoma: a clinicopathologic study on 313 patients. Eur J Gynaecol Oncol 2007;28:95-7. (Pubitemid 46697776)
15. Kauppila A, Gronroos M, Nieminen U. Clinical outcome in endometrial cancer. Obstet Gynecol 1982;60:473-80. (Pubitemid 12018877)
16. Folsom AR, Anderson KE, Sweeney C, JacobsDRJr. Diabetes as a risk factor for death following endometrial cancer. Gynecol Oncol 2004;94:740-5. (Pubitemid 39194469)
17. Chia VM, Newcomb PA, Trentham-Dietz A, Hampton JM. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis. Int J Gynecol Cancer 2007;17:441-6. (Pubitemid 46426761)
18. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002;40: IV-3-18.
19. Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM. Identifying persons with diabetes using Medicare claims data. Am J Med Qual 1999;14:270-7.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. (Pubitemid 17055592)
21. Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-54.
22. Papanas N, Giatromanolaki A, Galazios G, Maltezos E, Sivridis E. Endometrial carcinoma and diabetes revisited. Eur J Gynaecol Oncol 2006;27:505-8.
23. Linkov F, Edwards R, Balk J, Yurkovetsky Z, Stadterman B, Lokshin A, et al. Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors. Eur J Cancer 2008;44:1632-44.
24. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531-43. (Pubitemid 36020003)
25. Kashima H, Shiozawa T, Miyamoto T, Suzuki A, Uchikawa J, Kurai M, et al. Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E. Endocr Relat Cancer 2009;16:113-22.
26. Osei K. Metabolic syndrome in blacks: are the criteria right? Curr Diabetes Rep 2010;10:199-208.
27. Kucirka LM, Grams ME, Lessler J, Hall EC, James N, Massie AB, et al. Association of race and age with survival among patients undergoing dialysis. JAMA 2011;306:620-6.
28. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29:1263-8. (Pubitemid 44125920)
29. Cutler JA, Sorlie PD, Wolz M, ThomT, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008;52:818-27.
30. Armstrong K, Randall TC, Polsky D, Moye E, Silber JH. Racial differences in surgeons and hospitals for endometrial cancer treatment. Med Care 2011;49:207-14.
31. Onega T, Duell EJ, Shi X, Demidenko E, Goodman DC. Race versus place of service in mortality among medicare beneficiaries with cancer. Cancer 2010;116:2698-706.